Employee-related Liabilities, Current of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Employee-related Liabilities, Current for the quarter ending 30 Sep 2025 was $51,108,000, a 72% increase year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $51,108,000 +$21,424,000 +72% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $27,691,000 +$6,350,000 +30% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $18,272,000 +$1,320,000 +7.8% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $34,957,000 +$17,927,000 +105% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $29,684,000 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $21,341,000 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $16,952,000 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $17,030,000 +$2,166,000 +15% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 $14,864,000 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q2 2016 $714,000 -$2,281,000 -76% 30 Jun 2016 10-Q 20 Jul 2016 2016 Q2
Q1 2016 $1,349,000 -$1,256,000 -48% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $3,072,000 -$780,000 -20% 31 Dec 2015 10-Q 20 Jul 2016 2016 Q2
Q3 2015 $2,605,000 -$171,000 -6.2% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $2,995,000 +$309,000 +12% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $2,605,000 +$443,000 +20% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $3,852,000 +$715,000 +23% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 $2,776,000 +$514,000 +23% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $2,686,000 +$987,000 +58% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $2,162,000 +$1,004,000 +87% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $3,137,000 -$135,000 -4.1% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $2,262,000 +$283,000 +14% 30 Sep 2013 10-Q 04 Nov 2013 2013 Q3
Q2 2013 $1,699,000 +$280,000 +20% 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 $1,158,000 31 Mar 2013 10-Q 30 Apr 2013 2013 Q1
Q4 2012 $3,272,000 +$358,000 +12% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q3 2012 $1,979,000 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 $1,419,000 30 Jun 2012 10-Q 02 Aug 2012 2012 Q2
Q4 2011 $2,914,000 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.